TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2157082
log Bayes Factor = 53.5159
Chromosome 6   position 32,760,714  (GRCh37) Explore rs2157082 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E10.9 Without complications
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
G35 Multiple sclerosis
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.000 1.000
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.001 0.999
L40.5 Arthropathic psoriasis
0.000 0.001 0.999
E05.9 Thyrotoxicosis, unspecified
0.000 0.001 0.999
E11.3 With ophthalmic complications
0.000 0.001 0.999
E20-E35 Disorders of other endocrine glands
0.000 0.007 0.993
L40 Psoriasis
0.000 0.009 0.991
G35-G37 Demyelinating diseases of the central nervous system
0.990 0.010 0.000
G37 Other demyelinating diseases of central nervous system
0.987 0.013 0.000
H36.0 Diabetic retinopathy
0.000 0.014 0.986
E27 Other disorders of adrenal gland
0.000 0.021 0.979
G37.9 Demyelinating disease of central nervous system, unspecified
0.979 0.021 0.000
E10.1 With ketoacidosis
0.000 0.022 0.978
E03 Other hypothyroidism
0.000 0.023 0.977
C44 Other malignant neoplasms of skin
0.000 0.023 0.977
C44.6 Skin of upper limb, including shoulder
0.000 0.026 0.974
C44.7 Skin of lower limb, including hip
0.000 0.027 0.973
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.029 0.971
L40.9 Psoriasis, unspecified
0.000 0.031 0.969
E27.1 Primary adrenocortical insufficiency
0.000 0.032 0.968
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.032 0.968
E03.9 Hypothyroidism, unspecified
0.000 0.032 0.968
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.032 0.968
E11.9 Without complications
0.000 0.034 0.966
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.036 0.964
E10.2 With renal complications
0.000 0.037 0.963
L57.0 Actinic keratosis
0.000 0.040 0.960
E10.5 With peripheral circulatory complications
0.000 0.041 0.959
C43-C44 Melanoma and other malignant neoplasms of skin
0.000 0.046 0.954
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.049 0.951
C44.3 Skin of other and unspecified parts of face
0.000 0.049 0.951
D04 Carcinoma in situ of skin
0.000 0.054 0.946
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.055 0.945
D00-D09 In situ neoplasms
0.000 0.062 0.938
Chapter II Neoplasms
0.000 0.062 0.938
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.064 0.936
E10.4 With neurological complications
0.000 0.064 0.936
D04.5 Skin of trunk
0.000 0.074 0.926
C83.3 Large cell (diffuse)
0.000 0.079 0.921
E16 Other disorders of pancreatic internal secretion
0.000 0.084 0.916
G37.8 Other specified demyelinating diseases of central nervous system
0.897 0.103 0.000
L40-L45 Papulosquamous disorders
0.000 0.109 0.891
D04.7 Skin of lower limb, including hip
0.000 0.112 0.888
L57 Skin changes due to chronic exposure to nonionising radiation
0.000 0.119 0.881
D04.3 Skin of other and unspecified parts of face
0.000 0.120 0.880
E23 Hypofunction and other disorders of pituitary gland
0.000 0.122 0.878
C44.4 Skin of scalp and neck
0.000 0.135 0.865
C82.0 Small cleaved cell, follicular
0.000 0.143 0.857
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.000 0.147 0.853
E16.2 Hypoglycaemia, unspecified
0.000 0.153 0.847
E10.0 With coma
0.000 0.156 0.843
H36 Retinal disorders in diseases classified elsewhere
0.000 0.157 0.843
E11.0 With coma
0.000 0.158 0.841
L40.3 Pustulosis palmaris et plantaris
0.000 0.161 0.839
Chapter XII Diseases of the skin and subcutaneous tissue
0.000 0.165 0.835
C91 Lymphoid leukaemia
0.000 0.169 0.831
E28 Ovarian dysfunction
0.000 0.176 0.824
D09 Carcinoma in situ of other and unspecified sites
0.000 0.178 0.822
C82.2 Large cell, follicular
0.000 0.181 0.819
E11.5 With peripheral circulatory complications
0.000 0.187 0.813
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.187 0.813
E23.7 Disorder of pituitary gland, unspecified
0.000 0.192 0.808
L40.1 Generalised pustular psoriasis
0.000 0.194 0.806
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.000 0.196 0.804
E13 Other specified diabetes mellitus
0.000 0.197 0.803
E24 Cushing's syndrome
0.000 0.198 0.802
C88 Malignant immunoproliferative diseases
0.000 0.198 0.802
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.801 0.199 0.000
E70-E90 Metabolic disorders
0.000 0.201 0.799
C82.4 Follicular lymphoma grade IIIb
0.000 0.203 0.797
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.204 0.796
C85.1 B-cell lymphoma, unspecified
0.000 0.205 0.795
D04.4 Skin of scalp and neck
0.000 0.205 0.795
E10.7 With multiple complications
0.000 0.213 0.787
E89.0 Postprocedural hypothyroidism
0.000 0.216 0.784
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.217 0.783
E23.6 Other disorders of pituitary gland
0.000 0.221 0.779
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.221 0.779
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.222 0.778
C83.7 Burkitt's tumour
0.000 0.223 0.777
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.229 0.770
G36 Other acute disseminated demyelination
0.770 0.230 0.000
D04.6 Skin of upper limb, including shoulder
0.000 0.235 0.765
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.236 0.764
M07.3 Other psoriatic arthropathies
0.000 0.238 0.762
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.241 0.759
M07.30 Other psoriatic arthropathies (Multiple sites)
0.000 0.247 0.753
C91.9 Lymphoid leukaemia, unspecified
0.000 0.247 0.753
E10.6 With other specified complications
0.000 0.247 0.753
L40.4 Guttate psoriasis
0.000 0.248 0.751
E11.2 With renal complications
0.000 0.249 0.751
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.252 0.747
# Top node
0.000 0.258 0.742
H30-H36 Disorders of choroid and retina
0.000 0.259 0.741
D04.9 Skin, unspecified
0.000 0.264 0.736
E16.1 Other hypoglycaemia
0.000 0.265 0.735
C83.1 Small cleaved cell (diffuse)
0.000 0.269 0.731
D06 Carcinoma in situ of cervix uteri
0.000 0.269 0.731
D09.0 Bladder
0.000 0.270 0.730
E65-E68 Obesity and other hyperalimentation
0.000 0.271 0.729
D04.2 Skin of ear and external auricular canal
0.000 0.273 0.727
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.274 0.726
C73 Malignant neoplasm of thyroid gland
0.000 0.276 0.724
H35 Other retinal disorders
0.000 0.280 0.720
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.286 0.714
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.286 0.714
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.000 0.287 0.713
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.288 0.712
E32 Diseases of thymus
0.000 0.288 0.712
E31 Polyglandular dysfunction
0.000 0.288 0.712
E30 Disorders of puberty, not elsewhere classified
0.000 0.288 0.712
L40.2 Acrodermatitis continua
0.000 0.289 0.711
G37.5 Concentric sclerosis [Balo]
0.708 0.292 0.000
G37.4 Subacute necrotising myelitis
0.708 0.292 0.000
G37.2 Central pontine myelinolysis
0.708 0.292 0.000
G37.1 Central demyelination of corpus callosum
0.708 0.292 0.000
G37.0 Diffuse sclerosis
0.708 0.292 0.000
E10.8 With unspecified complications
0.000 0.293 0.707
E40-E46 Malnutrition
0.000 0.295 0.705
E03.1 Congenital hypothyroidism without goitre
0.000 0.297 0.703
E27.2 Addisonian crisis
0.000 0.297 0.703
E27.5 Adrenomedullary hyperfunction
0.000 0.298 0.702
E27.0 Other adrenocortical overactivity
0.000 0.298 0.702
E03.5 Myxoedema coma
0.000 0.300 0.700
E03.4 Atrophy of thyroid (acquired)
0.000 0.300 0.700
E03.3 Postinfectious hypothyroidism
0.000 0.300 0.700
C44.8 Overlapping lesion of skin
0.000 0.300 0.700
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.301 0.699
C43 Malignant melanoma of skin
0.000 0.301 0.699
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.304 0.696
M07.36 Other psoriatic arthropathies (Lower leg)
0.000 0.304 0.696
E26 Hyperaldosteronism
0.000 0.305 0.695
C82.6 Cutaneous follicle centre lymphoma
0.000 0.306 0.694
C82.5 Diffuse follicle centre lymphoma
0.000 0.306 0.694
C85.0 Lymphosarcoma
0.000 0.306 0.694
C91.0 Acute lymphoblastic leukaemia
0.000 0.311 0.689
E05.8 Other thyrotoxicosis
0.000 0.314 0.686
E15 Nondiabetic hypoglycaemic coma
0.000 0.318 0.682
E29 Testicular dysfunction
0.000 0.319 0.681
Chapter VII Diseases of the eye and adnexa
0.000 0.319 0.681
E06 Thyroiditis
0.000 0.320 0.680
D04.1 Skin of eyelid, including canthus
0.000 0.321 0.679
E28.2 Polycystic ovarian syndrome
0.000 0.322 0.678
D04.8 Skin of other sites
0.000 0.322 0.678
D04.0 Skin of lip
0.000 0.322 0.678
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.000 0.325 0.675
C94 Other leukaemias of specified cell type
0.000 0.326 0.674
H35.2 Other proliferative retinopathy
0.000 0.326 0.674
C44.0 Skin of lip
0.000 0.326 0.674
E24.2 Drug-induced Cushing's syndrome
0.000 0.327 0.673
H35.8 Other specified retinal disorders
0.000 0.327 0.673
C83.6 Undifferentiated (diffuse)
0.000 0.329 0.671
C83.4 Immunoblastic (diffuse)
0.000 0.329 0.671
C83.2 Mixed small and large cell (diffuse)
0.000 0.329 0.671
E22 Hyperfunction of pituitary gland
0.000 0.332 0.668
E25 Adrenogenital disorders
0.000 0.332 0.668
E11.8 With unspecified complications
0.000 0.333 0.667
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.338 0.662
E79 Disorders of purine and pyrimidine metabolism
0.000 0.339 0.661
L43 Lichen planus
0.000 0.340 0.660
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.000 0.341 0.659
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.343 0.657
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.343 0.657
E16.4 Abnormal secretion of gastrin
0.000 0.343 0.657
E16.3 Increased secretion of glucagon
0.000 0.343 0.657
C86 Other specified types of T/NK-cell lymphoma
0.000 0.345 0.654
C91.5 Adult T-cell leukaemia
0.000 0.346 0.654
C93 Monocytic leukaemia
0.000 0.347 0.653
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.348 0.652
D03 Melanoma in situ
0.000 0.353 0.647
E21.3 Hyperparathyroidism, unspecified
0.000 0.353 0.647
D02 Carcinoma in situ of middle ear and respiratory system
0.000 0.353 0.647
E78.6 Lipoprotein deficiency
0.000 0.354 0.646
C44.2 Skin of ear and external auricular canal
0.000 0.355 0.645
E89.3 Postprocedural hypopituitarism
0.000 0.355 0.645
L44 Other papulosquamous disorders
0.000 0.361 0.639
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.361 0.639
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.365 0.635
E65 Localised adiposity
0.000 0.367 0.633
E28.3 Primary ovarian failure
0.000 0.368 0.632
L57.5 Actinic granuloma
0.000 0.368 0.631
L57.3 Poikiloderma of Civatte
0.000 0.368 0.631
L57.2 Cutis rhomboidalis nuchae
0.000 0.368 0.631
L57.1 Actinic reticuloid
0.000 0.368 0.631
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.371 0.629
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.371 0.629
E23.1 Drug-induced hypopituitarism
0.000 0.371 0.629
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.000 0.374 0.626
E13.3 With ophthalmic complications
0.000 0.374 0.626
E27.8 Other specified disorders of adrenal gland
0.000 0.374 0.626
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.000 0.375 0.625
C95 Leukaemia of unspecified cell type
0.000 0.376 0.623
E03.8 Other specified hypothyroidism
0.000 0.376 0.623
E11.6 With other specified complications
0.000 0.377 0.623
E78.2 Mixed hyperlipidaemia
0.000 0.378 0.622
E27.9 Disorder of adrenal gland, unspecified
0.000 0.378 0.621
E13.9 Without complications
0.000 0.379 0.621
E89.4 Postprocedural ovarian failure
0.000 0.379 0.621
L41 Parapsoriasis
0.000 0.379 0.620
L40.0 Psoriasis vulgaris
0.000 0.381 0.619
E24.0 Pituitary-dependent Cushing's disease
0.000 0.381 0.619
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.000 0.382 0.618
E89.2 Postprocedural hypoparathyroidism
0.000 0.382 0.618
D06.9 Cervix, unspecified
0.000 0.383 0.617
E20 Hypoparathyroidism
0.000 0.384 0.616
C83.5 Lymphoblastic (diffuse)
0.000 0.386 0.614
H35.6 Retinal haemorrhage
0.000 0.387 0.613
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.388 0.612
M07.34 Other psoriatic arthropathies (Hand)
0.000 0.388 0.612
C82.3 Follicular lymphoma grade IIIa
0.000 0.388 0.612
G36.0 Neuromyelitis optica [Devic]
0.612 0.388 0.000
L55 Sunburn
0.000 0.388 0.611
L56 Other acute skin changes due to ultraviolet radiation
0.000 0.390 0.610
D01 Carcinoma in situ of other and unspecified digestive organs
0.000 0.392 0.608
H36.8 Other retinal disorders in diseases classified elsewhere
0.000 0.395 0.605
D09.9 Carcinoma in situ, unspecified
0.000 0.396 0.604
Q80-Q89 Other congenital malformations
0.000 0.397 0.603
E88 Other metabolic disorders
0.000 0.400 0.600
E70 Disorders of aromatic amino-acid metabolism
0.000 0.401 0.599
H30 Chorioretinal inflammation
0.000 0.402 0.598
D09.1 Other and unspecified urinary organs
0.000 0.402 0.597
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.404 0.596
C91.7 Other lymphoid leukaemia
0.000 0.404 0.596
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.404 0.596
C91.3 Prolymphocytic leukaemia
0.000 0.404 0.596
C91.2 Subacute lymphocytic leukaemia
0.000 0.404 0.596
C74 Malignant neoplasm of adrenal gland
0.000 0.404 0.596
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.000 0.405 0.595
L10-L14 Bullous disorders
0.000 0.407 0.593
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.000 0.407 0.592
E21.4 Other specified disorders of parathyroid gland
0.000 0.408 0.592
Q85 Phakomatoses, not elsewhere classified
0.000 0.409 0.591
E28.9 Ovarian dysfunction, unspecified
0.000 0.409 0.591
E28.8 Other ovarian dysfunction
0.000 0.409 0.591
E28.1 Androgen excess
0.000 0.409 0.591
E28.0 Oestrogen excess
0.000 0.409 0.591
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.409 0.591
E06.3 Autoimmune thyroiditis
0.000 0.411 0.589
D09.7 Carcinoma in situ of other specified sites
0.000 0.411 0.589
D09.3 Thyroid and other endocrine glands
0.000 0.411 0.589
D09.2 Eye
0.000 0.411 0.589
H35.0 Background retinopathy and retinal vascular changes
0.000 0.412 0.588
E34 Other endocrine disorders
0.000 0.412 0.588
H83.0 Labyrinthitis
0.000 0.413 0.587
D37-D48 Neoplasms of uncertain or unknown behaviour
0.000 0.416 0.584
Chapter VIII Diseases of the ear and mastoid process
0.000 0.416 0.584
C43.6 Malignant melanoma of upper limb, including shoulder
0.000 0.416 0.584
H83 Other diseases of inner ear
0.000 0.417 0.583
C40-C41 Malignant neoplasms of bone and articular cartilage
0.000 0.419 0.580
H80-H83 Diseases of inner ear
0.000 0.423 0.577
L58 Radiodermatitis
0.000 0.423 0.577
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.423 0.577
D00.1 Oesophagus
0.000 0.424 0.576
E13.8 With unspecified complications
0.000 0.424 0.576
E13.7 With multiple complications
0.000 0.424 0.576
E13.6 With other specified complications
0.000 0.424 0.576
E13.5 With peripheral circulatory complications
0.000 0.424 0.576
E13.4 With neurological complications
0.000 0.424 0.576
E13.2 With renal complications
0.000 0.424 0.576
E13.1 With ketoacidosis
0.000 0.424 0.576
E13.0 With coma
0.000 0.424 0.576
E24.8 Other Cushing's syndrome
0.000 0.425 0.575
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.425 0.575
E24.3 Ectopic ACTH syndrome
0.000 0.425 0.575
E24.1 Nelson's syndrome
0.000 0.425 0.575
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.425 0.575
C88.7 Other malignant immunoproliferative diseases
0.000 0.425 0.575
C88.3 Immunoproliferative small intestinal disease
0.000 0.425 0.575
C88.2 Gamma heavy chain disease
0.000 0.425 0.575
C88.1 Alpha heavy chain disease
0.000 0.425 0.575
E78.5 Hyperlipidaemia, unspecified
0.000 0.427 0.573
E77 Disorders of glycoprotein metabolism
0.000 0.427 0.573
E76 Disorders of glycosaminoglycan metabolism
0.000 0.427 0.573
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.427 0.573
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.427 0.573
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.429 0.571
E89.5 Postprocedural testicular hypofunction
0.000 0.429 0.571
E07 Other disorders of thyroid
0.000 0.430 0.570
E84 Cystic fibrosis
0.000 0.431 0.569
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.000 0.433 0.567
E21.2 Other hyperparathyroidism
0.000 0.434 0.566
Q60-Q64 Congenital malformations of the urinary system
0.000 0.437 0.563
L42 Pityriasis rosea
0.000 0.437 0.563
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.438 0.562
D03.5 Melanoma in situ of trunk
0.000 0.439 0.561
C12 Malignant neoplasm of pyriform sinus
0.000 0.440 0.560
Q50-Q56 Congenital malformations of genital organs
0.000 0.442 0.558
E26.9 Hyperaldosteronism, unspecified
0.000 0.442 0.558
Q85.8 Other phakomatoses, not elsewhere classified
0.000 0.442 0.558
E85 Amyloidosis
0.000 0.446 0.554
Q61 Cystic kidney disease
0.000 0.446 0.554
G36.9 Acute disseminated demyelination, unspecified
0.552 0.448 0.000
G36.8 Other specified acute disseminated demyelination
0.552 0.448 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.552 0.448 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.449 0.551
C43.2 Malignant melanoma of ear and external auricular canal
0.000 0.449 0.550
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.453 0.547
M07.38 Other psoriatic arthropathies (Other)
0.000 0.454 0.546
M07.33 Other psoriatic arthropathies (Forearm)
0.000 0.454 0.546
M07.32 Other psoriatic arthropathies (Upper arm)
0.000 0.454 0.546
M07.31 Other psoriatic arthropathies (Shoulder region)
0.000 0.454 0.546
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.457 0.543
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.459 0.541
D43.0 Brain, supratentorial
0.000 0.459 0.541
E89.1 Postprocedural hypoinsulinaemia
0.000 0.461 0.539
Chapter XVI Certain conditions originating in the perinatal period
0.000 0.463 0.537
E22.1 Hyperprolactinaemia
0.000 0.467 0.533
C81 Hodgkin's disease
0.000 0.468 0.532
H32 Chorioretinal disorders in diseases classified elsewhere
0.000 0.469 0.531
C02 Malignant neoplasm of other and unspecified parts of tongue
0.000 0.469 0.530
E78.1 Pure hyperglyceridaemia
0.000 0.471 0.529
Q85.9 Phakomatosis, unspecified
0.000 0.471 0.529
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction
0.000 0.473 0.527
D03.2 Melanoma in situ of ear and external auricular canal
0.000 0.476 0.524
D06.7 Other parts of cervix
0.000 0.476 0.524
C91.4 Hairy-cell leukaemia
0.000 0.477 0.523
E67 Other hyperalimentation
0.000 0.477 0.523
E68 Sequelae of hyperalimentation
0.000 0.477 0.523
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.479 0.521
H35.1 Retinopathy of prematurity
0.000 0.483 0.516
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
Q61.3 Polycystic kidney, unspecified
0.000 0.486 0.514
L40.8 Other psoriasis
0.000 0.487 0.513
D06.1 Exocervix
0.000 0.488 0.512
D00.2 Stomach
0.000 0.489 0.511
E30.9 Disorder of puberty, unspecified
0.000 0.490 0.510
E30.8 Other disorders of puberty
0.000 0.490 0.510
E30.1 Precocious puberty
0.000 0.490 0.510
E30.0 Delayed puberty
0.000 0.490 0.510
E31.9 Polyglandular dysfunction, unspecified
0.000 0.490 0.510
E31.8 Other polyglandular dysfunction
0.000 0.490 0.510
E31.1 Polyglandular hyperfunction
0.000 0.490 0.510
E31.0 Autoimmune polyglandular failure
0.000 0.490 0.510
E32.9 Disease of thymus, unspecified
0.000 0.490 0.510
E32.8 Other diseases of thymus
0.000 0.490 0.510
E32.1 Abscess of thymus
0.000 0.490 0.510
E32.0 Persistent hyperplasia of thymus
0.000 0.490 0.510
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.490 0.510
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.490 0.510
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.490 0.510
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.492 0.508
C75 Malignant neoplasm of other endocrine glands and related structures
0.000 0.492 0.508
H50 Other strabismus
0.000 0.494 0.506
L43.8 Other lichen planus
0.000 0.494 0.506
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.495 0.505
E45 Retarded development following protein-energy malnutrition
0.000 0.495 0.505
E43 Unspecified severe protein-energy malnutrition
0.000 0.495 0.505
E42 Marasmic kwashiorkor
0.000 0.495 0.505
E41 Nutritional marasmus
0.000 0.495 0.505
E40 Kwashiorkor
0.000 0.495 0.505
E24.9 Cushing's syndrome, unspecified
0.000 0.498 0.502
C43.8 Overlapping malignant melanoma of skin
0.000 0.499 0.501
C43.0 Malignant melanoma of lip
0.000 0.499 0.501
E88.8 Other specified metabolic disorders
0.000 0.499 0.501
Q61.0 Congenital single renal cyst
0.000 0.499 0.501
L57.4 Cutis laxa senilis
0.000 0.500 0.500
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.501 0.499
C96.8 Histiocytic sarcoma
0.000 0.501 0.499
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.501 0.499
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.501 0.499
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.501 0.499
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.501 0.499
C96.3 True histiocytic lymphoma
0.000 0.501 0.499
C96.2 Malignant mast cell tumour
0.000 0.501 0.499
C96.1 Malignant histiocytosis
0.000 0.501 0.499
C96.0 Letterer-Siwe disease
0.000 0.501 0.499
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.501 0.499
E29.1 Testicular hypofunction
0.000 0.501 0.499
E73 Lactose intolerance
0.000 0.501 0.499
E26.8 Other hyperaldosteronism
0.000 0.501 0.499
E26.1 Secondary hyperaldosteronism
0.000 0.501 0.499
D01.0 Colon
0.000 0.504 0.496
H30.9 Chorioretinal inflammation, unspecified
0.000 0.504 0.496
C11 Malignant neoplasm of nasopharynx
0.000 0.504 0.496
C08 Malignant neoplasm of other and unspecified major salivary glands
0.000 0.504 0.496
E11.1 With ketoacidosis
0.000 0.505 0.495
E46 Unspecified protein-energy malnutrition
0.000 0.507 0.493
D43.2 Brain, unspecified
0.000 0.509 0.491
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.510 0.490
H35.5 Hereditary retinal dystrophy
0.000 0.511 0.489
H53-H54 Visual disturbances and blindness
0.000 0.511 0.489
H50.0 Convergent concomitant strabismus
0.000 0.511 0.489
E29.8 Other testicular dysfunction
0.000 0.512 0.488
E29.0 Testicular hyperfunction
0.000 0.512 0.488
E06.4 Drug-induced thyroiditis
0.000 0.512 0.487
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.512 0.487
E06.0 Acute thyroiditis
0.000 0.512 0.487
C97 Malignant neoplasms of independent (primary) multiple sites
0.000 0.513 0.487
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.513 0.487
C94.7 Other specified leukaemias
0.000 0.516 0.483
C94.5 Acute myelofibrosis
0.000 0.516 0.483
C94.4 Acute panmyelosis
0.000 0.516 0.483
C94.3 Mast cell leukaemia
0.000 0.516 0.483
C94.2 Acute megakaryoblastic leukaemia
0.000 0.516 0.483
C94.1 Chronic erythraemia
0.000 0.516 0.483
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.516 0.483
Q83 Congenital malformations of breast
0.000 0.517 0.483
Q61.9 Cystic kidney disease, unspecified
0.000 0.518 0.482
L56.9 Acute skin change due to ultraviolet radiation, unspecified
0.000 0.519 0.481
C43.7 Malignant melanoma of lower limb, including hip
0.000 0.519 0.481
H35.3 Degeneration of macula and posterior pole
0.000 0.520 0.480
C03 Malignant neoplasm of gum
0.000 0.521 0.479
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.521 0.479
E22.8 Other hyperfunction of pituitary gland
0.000 0.521 0.479
E25.9 Adrenogenital disorder, unspecified
0.000 0.521 0.479
E25.8 Other adrenogenital disorders
0.000 0.521 0.479
D00.0 Lip, oral cavity and pharynx
0.000 0.523 0.477
D06.0 Endocervix
0.000 0.525 0.474
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.526 0.474
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.526 0.474
E79.1 Lesch-Nyhan syndrome
0.000 0.526 0.474
L43.3 Subacute (active) lichen planus
0.000 0.527 0.473
L43.2 Lichenoid drug reaction
0.000 0.527 0.473
L43.1 Bullous lichen planus
0.000 0.527 0.473
L43.0 Hypertrophic lichen planus
0.000 0.527 0.473
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.000 0.527 0.473
E06.5 Other chronic thyroiditis
0.000 0.528 0.472
H83.3 Noise effects on inner ear
0.000 0.530 0.470
E72 Other disorders of amino-acid metabolism
0.000 0.530 0.470
C95.0 Acute leukaemia of unspecified cell type
0.000 0.530 0.469
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.531 0.469
C86.4 Blastic NK-cell lymphoma
0.000 0.531 0.469
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.531 0.469
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.531 0.469
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.531 0.469
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.531 0.469
E83.1 Disorders of iron metabolism
0.468 0.532 0.001
C93.9 Monocytic leukaemia, unspecified
0.000 0.532 0.468
C93.7 Other monocytic leukaemia
0.000 0.532 0.468
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.532 0.468
C93.2 Subacute monocytic leukaemia
0.000 0.532 0.468
C93.0 Acute monocytic leukaemia
0.000 0.532 0.468
H35.4 Peripheral retinal degeneration
0.000 0.533 0.467
Q85.0 Neurofibromatosis (nonmalignant)
0.000 0.533 0.467
D03.0 Melanoma in situ of lip
0.000 0.533 0.467
Q51 Congenital malformations of uterus and cervix
0.000 0.534 0.466
C02.9 Tongue, unspecified
0.000 0.535 0.465
H83.9 Disease of inner ear, unspecified
0.000 0.536 0.464
D03.9 Melanoma in situ, unspecified
0.000 0.536 0.464
D47.2 Monoclonal gammopathy
0.000 0.536 0.464
D02.4 Respiratory system, unspecified
0.000 0.536 0.464
D02.3 Other parts of respiratory system
0.000 0.536 0.464
D02.2 Bronchus and lung
0.000 0.536 0.464
D02.1 Trachea
0.000 0.536 0.464
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.537 0.463
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation
0.000 0.538 0.462
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.538 0.461
E78.8 Other disorders of lipoprotein metabolism
0.000 0.539 0.461
L12 Pemphigoid
0.000 0.540 0.460
E14 Unspecified diabetes mellitus
0.000 0.540 0.460
L43.9 Lichen planus, unspecified
0.000 0.541 0.459
Q53 Undescended testicle
0.000 0.541 0.459
L44.9 Papulosquamous disorder, unspecified
0.000 0.542 0.458
L44.8 Other specified papulosquamous disorders
0.000 0.542 0.458
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.542 0.458
L44.3 Lichen ruber moniliformis
0.000 0.542 0.458
L44.2 Lichen striatus
0.000 0.542 0.458
L44.1 Lichen nitidus
0.000 0.542 0.458
L44.0 Pityriasis rubra pilaris
0.000 0.542 0.458
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.000 0.543 0.457
E70.3 Albinism
0.000 0.544 0.456
D03.7 Melanoma in situ of lower limb, including hip
0.000 0.544 0.456
C74.0 Cortex of adrenal gland
0.000 0.544 0.455
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.000 0.545 0.455
C84.5 Other and unspecified T-cell lymphomas
0.000 0.545 0.455
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.545 0.455

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.